Journal
MOVEMENT DISORDERS
Volume 25, Issue 3, Pages S110-S116Publisher
WILEY-LISS
DOI: 10.1002/mds.22787
Keywords
Parkinson's disease; dementia; cognitive impairment
Categories
Funding
- NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024156] Funding Source: NIH RePORTER
- NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036630] Funding Source: NIH RePORTER
- NCRR NIH HHS [UL1 RR024156] Funding Source: Medline
- NINDS NIH HHS [R01 NS36630] Funding Source: Medline
Ask authors/readers for more resources
Over the last decade, the importance of cognitive impairment and dementia in Parkinson's disease (PDD) has been increasingly recognized. Investigators have proposed criteria for PD dementia, and mild cognitive impairment. Risk profiles associated with the development of dementia based on demographic, neurological, neuropsychological, imaging, and genetic investigations have been delineated. The FDA has approved a treatment for PDD, and efforts now are directed toward intervention at earlier stages of cognitive impairment. (C) 2010 Movement Disorder Society
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
